-
Bayer HealthCare Pharmaceuticals has received Food and Drug Administration approval for a new inserter for its Mirena intrauterine contraceptive.
-
New chlamydia prevalence estimates confirm that young women particularly young African American women continue to bear a disproportionate burden of disease in the United States.
-
Results from the 2013 National Youth Risk Behavior Survey indicate that among high school students who are sexually active, condom use has declined from 63% in 2003 to 59% in 2013. This decline follows a period of increased condom use throughout the 1990s and early 2000s.
-
Its estimated that 859 out of 100,000 women of reproductive age receive a cancer diagnosis each year in the United States. Up to 80% of all women diagnosed with cancer prior to age 50 survive at least five years.
-
A new campaign, Start Talking. Stop HIV, developed by the Centers for Disease Control and Prevention encourages gay and bisexual men to talk openly with their sexual partners about HIV risk and prevention strategies.
-
Reproductive health advocates are moving quickly following the June 30 Supreme Court ruling that closely held corporations that assert a religious objection do not have to cover contraceptive services and methods in their employer-sponsored health plans as required under the Affordable Care Act.
-
Get up to speed on the latest testing and treatment modalities on the hepatitis C virus (HCV) by watching the archived webcast of the Centers for Disease Control and Preventions (CDCs) Public Health Grand Rounds: The 25th anniversary of the discovery of the hepatitis C virus: looking back to look forward.
-
Up to 90% of female adolescents report experiencing painful periods or other menstrual complaints. Problems associated with menses are the primary reported cause for absenteeism from school and work for female adolescents. While diagnosis and treatment differ depending on specific menstrual disorders or complaints, contraceptive methods often offer a solution for teens and adults.
-
The Centers for Disease Control and Prevention has issued a new approach for HIV testing in laboratories that capitalizes on the latest technology to improve diagnosis of acute infection, the earliest stage of HIV infection when people are most likely to transmit the virus.
-
A review of the published literature finds no value to the routine screening pelvic examination in asymptomatic non-pregnant women.
